The scientist’s investigation covers issues in Pharmacology, Drug discovery, Drug development, Virology and Internal medicine. His work on Drug repositioning as part of general Pharmacology study is frequently connected to Chemokine receptor CCR5, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His work deals with themes such as High-throughput screening, Flux, Structure–activity relationship, Computational biology and High Throughput Assay, which intersect with Drug discovery.
His studies deal with areas such as Translational science, Equipment failure and Disease as well as Drug development. His Virology study combines topics in areas such as Druggability and Plasmodium falciparum. His Internal medicine research focuses on subjects like Endocrinology, which are linked to Intracellular.
His primary scientific interests are in Biochemistry, Molecular biology, Cancer research, Cell biology and Pharmacology. His study involves Enzyme, Small molecule, High-throughput screening, Glucocerebrosidase and Enzyme assay, a branch of Biochemistry. His research investigates the connection between Molecular biology and topics such as Cell culture that intersect with issues in Cell.
His work in Cancer research tackles topics such as Induced pluripotent stem cell which are related to areas like Neural stem cell, Mutation, Disease, Pathophysiology and Lysosomal storage disease. His Drug and Drug repositioning study are his primary interests in Pharmacology. His Drug research focuses on Drug discovery and how it relates to Computational biology.
His main research concerns Drug, Induced pluripotent stem cell, Cancer research, Drug repositioning and Drug development. His Drug research is multidisciplinary, incorporating elements of High-throughput screening, Drug resistance, Small molecule and Virology. The various areas that Wei Zheng examines in his Induced pluripotent stem cell study include Cell, Mutation, Molecular biology, Pathophysiology and Disease.
His Cancer research research incorporates themes from Cell culture, Ovarian cancer, In vivo and Exon. Pharmacology covers he research in Drug repositioning. In his study, which falls under the umbrella issue of Drug development, Computational biology is strongly linked to Drug discovery.
Wei Zheng mainly investigates Drug repositioning, Drug, Drug development, Disease and Pharmacology. Wei Zheng has included themes like Cytopathic effect, Virus and Approved drug in his Drug repositioning study. His Drug research includes themes of Protease and High-throughput screening.
His Drug development research integrates issues from Zika virus and Virology. The concepts of his Disease study are interwoven with issues in Phenotype, Efficacy, Drug discovery and Intensive care medicine. The study incorporates disciplines such as Computational biology and Neuroscience in addition to Drug discovery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
James Inglese;Douglas S. Auld;Ajit Jadhav;Ronald L. Johnson.
Proceedings of the National Academy of Sciences of the United States of America (2006)
High-throughput screening assays for the identification of chemical probes
James Inglese;Ronald L Johnson;Anton Simeonov;Menghang Xia.
Nature Chemical Biology (2007)
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
Miao Xu;Emily M. Lee;Zhexing Wen;Yichen Cheng.
Nature Medicine (2016)
Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays.
Kelli Solly;Xiaobo Wang;Xiao Xu;Berta Strulovici.
Assay and Drug Development Technologies (2004)
Phenotypic screens as a renewed approach for drug discovery
Wei Zheng;Natasha Thorne;John C. McKew.
Drug Discovery Today (2013)
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Alicia Cole;Zezhou Wang;Etienne Coyaud;Veronique Voisin.
Cancer Cell (2015)
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
Jennifer Kouznetsova;Wei Sun;Carles Martínez-Romero;Gregory Tawa.
Emerging microbes & infections (2014)
Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor
J. Hesselgesser;H. P. Ng;Meina Liang;Wei Zheng.
Journal of Biological Chemistry (1998)
Increased Expression of the Cardiac L-type Calcium Channel in Estrogen Receptor–deficient Mice
Barry D. Johnson;Wei Zheng;Kenneth S. Korach;Todd Scheuer.
The Journal of General Physiology (1997)
Epitranscriptomic m6A Regulation of Axon Regeneration in the Adult Mammalian Nervous System.
Yi-Lan Weng;Yi-Lan Weng;Xu Wang;Ran An;Jessica Cassin.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: